SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-016541
Filing Date
2017-08-08
Accepted
2017-08-08 16:20:02
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q aimt-10q_20170630.htm 10-Q 1894781
2 EX-10.2 aimt-ex102_251.htm EX-10.2 292575
3 EX-31.1 aimt-ex311_7.htm EX-31.1 19484
4 EX-31.2 aimt-ex312_6.htm EX-31.2 19460
5 EX-32.1 aimt-ex321_8.htm EX-32.1 16908
6 GRAPHIC g201708072304116852221.jpg GRAPHIC 35476
7 GRAPHIC g201708072304136332222.jpg GRAPHIC 38099
8 GRAPHIC g201708072304087432220.jpg GRAPHIC 21493
  Complete submission text file 0001564590-17-016541.txt   5944800

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT aimt-20170630.xml EX-101.INS 1224628
10 XBRL TAXONOMY EXTENSION SCHEMA aimt-20170630.xsd EX-101.SCH 28434
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aimt-20170630_cal.xml EX-101.CAL 32734
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aimt-20170630_def.xml EX-101.DEF 84459
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE aimt-20170630_lab.xml EX-101.LAB 258051
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aimt-20170630_pre.xml EX-101.PRE 188543
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37519 | Film No.: 171015047
SIC: 2834 Pharmaceutical Preparations